LOCUS       NP_036833                466 aa                     ROD 27-APR-2014
DEFINITION  beta-1 adrenergic receptor [Rattus norvegicus].
ACCESSION   NP_036833
VERSION     NP_036833.1  GI:6978459
KEYWORDS    RefSeq.
SOURCE      Rattus norvegicus (Norway rat)
  ORGANISM  Rattus norvegicus
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia;
            Sciurognathi; Muroidea; Muridae; Murinae; Rattus.
REFERENCE   1  (residues 1 to 466)
  AUTHORS   Somvanshi RK, Zou S, Qiu X and Kumar U.
  TITLE     Somatostatin receptor-2 negatively regulates beta-adrenergic
            receptor mediated Ca(2+) dependent signaling pathways in H9c2 cells
  JOURNAL   Biochim. Biophys. Acta 1843 (4), 735-745 (2014)
   PUBMED   24412308
  REMARK    GeneRIF: we report that somatostatin receptor 2 (SSTR2) plays a
            crucial role in modulation of b1AR and b2AR mediated signaling
            pathways that are associated with increased intracellular Ca(2+)
REFERENCE   2  (residues 1 to 466)
  AUTHORS   Morioka N, Abe H, Araki R, Matsumoto N, Zhang FF, Nakamura Y,
            Hisaoka-Nakashima K and Nakata Y.
  TITLE     A beta1/2 adrenergic receptor-sensitive intracellular signaling
            pathway modulates CCL2 production in cultured spinal astrocytes
  JOURNAL   J. Cell. Physiol. 229 (3), 323-332 (2014)
   PUBMED   24037783
  REMARK    GeneRIF: Suggest Adrb1/2 system in spinal astrocytes could play a
            key role in spinal functioning through the regulation of JNK1
            activity and CCL2 production.
REFERENCE   3  (residues 1 to 466)
  AUTHORS   Li X, Nooh MM and Bahouth SW.
  TITLE     Role of AKAP79/150 protein in beta1-adrenergic receptor trafficking
            and signaling in mammalian cells
  JOURNAL   J. Biol. Chem. 288 (47), 33797-33812 (2013)
   PUBMED   24121510
  REMARK    GeneRIF: a significant role for the AKAP5 scaffold in signaling and
            trafficking of the beta1-AR in cardiac myocytes and mammalian cells.
REFERENCE   4  (residues 1 to 466)
  AUTHORS   Cannavo A, Rengo G, Liccardo D, Pagano G, Zincarelli C, De Angelis
            MC, Puglia R, Di Pietro E, Rabinowitz JE, Barone MV, Cirillo P,
            Trimarco B, Palmer TM, Ferrara N, Koch WJ, Leosco D and Rapacciuolo
            A.
  TITLE     beta1-adrenergic receptor and sphingosine-1-phosphate receptor 1
            (S1PR1) reciprocal downregulation influences cardiac hypertrophic
            response and progression to heart failure: protective role of S1PR1
            cardiac gene therapy
  JOURNAL   Circulation 128 (15), 1612-1622 (2013)
   PUBMED   23969695
  REMARK    GeneRIF: We demonstrate that restoration of cardiac plasma membrane
            levels of S1PR1 produces beneficial effects that counterbalance the
            deleterious beta1AR overstimulation in heart failure.
REFERENCE   5  (residues 1 to 466)
  AUTHORS   Kim Y, Chen L, McCarley RW and Strecker RE.
  TITLE     Sleep allostasis in chronic sleep restriction: the role of the
            norepinephrine system
  JOURNAL   Brain Res. 1531, 9-16 (2013)
   PUBMED   23916734
  REMARK    GeneRIF: During the period of sleep deprivation, mRNA levels of
            adrenergic beta 1 receptors were reduced in frontal cortex.
REFERENCE   6  (residues 1 to 466)
  AUTHORS   Sala R, Moriggi E, Della Bella D and Carenzi A.
  TITLE     The specific binding of broxaterol, a new beta 2-selective agonist,
            to beta-adrenoceptors
  JOURNAL   Eur. J. Pharmacol. 203 (1), 17-23 (1991)
   PUBMED   1686765
REFERENCE   7  (residues 1 to 466)
  AUTHORS   Steinfath M, Geertz B, Schmitz W, Scholz H, Haverich A, Breil I,
            Hanrath P, Reupcke C, Sigmund M and Lo HB.
  TITLE     Distinct down-regulation of cardiac beta 1- and beta 2-adrenoceptors
            in different human heart diseases
  JOURNAL   Naunyn Schmiedebergs Arch. Pharmacol. 343 (2), 217-220 (1991)
   PUBMED   1648674
REFERENCE   8  (residues 1 to 466)
  AUTHORS   Shimomura H and Terada A.
  TITLE     Primary structure of the rat beta-1 adrenergic receptor gene
  JOURNAL   Nucleic Acids Res. 18 (15), 4591 (1990)
   PUBMED   2167473
REFERENCE   9  (residues 1 to 466)
  AUTHORS   Machida CA, Bunzow JR, Searles RP, Van Tol H, Tester B, Neve KA,
            Teal P, Nipper V and Civelli O.
  TITLE     Molecular cloning and expression of the rat beta 1-adrenergic
            receptor gene
  JOURNAL   J. Biol. Chem. 265 (22), 12960-12965 (1990)
   PUBMED   1695899
REFERENCE   10  (residues 1 to 466)
  AUTHORS   Rothwell,N.J., Stock,M.J. and Sudera,D.K.
  TITLE     Beta-adrenoreceptors in rat brown adipose tissue: proportions of
            beta 1- and beta 2-subtypes
  JOURNAL   Am. J. Physiol. 248 (4 PT 1), E397-E402 (1985)
   PUBMED   2858976
COMMENT     PROVISIONAL REFSEQ: This record has not yet been subject to final
            NCBI review. The reference sequence was derived from J05561.1.
            On Jun 25, 2006 this sequence version replaced gi:109464049.
            Summary: binds beta-adrenergic receptor agonists isoproterenol,
            norepinephrine, and epinephrine; mediates adenylylcyclase
            induction; involved in regulation of calcium current [RGD, Feb
            2006].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
FEATURES             Location/Qualifiers
     source          1..466
                     /db_xref="taxon:10116"
                     /organism="Rattus norvegicus"
                     /chromosome="1"
                     /map="1q55"
     Protein         1..466
                     /note="beta-1 adrenoceptor; beta-1 adrenoreceptor; beta
                     1-adrenergic receptor beta 1-AR; adrenergic receptor, beta
                     1; adrenergic, beta-1-, receptor"
                     /product="beta-1 adrenergic receptor"
                     /calculated_mol_wt="50341"
     Site            56..84
                     /note="propagated from UniProtKB/Swiss-Prot (P18090.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          76..>266
                     /note="Serpentine type 7TM GPCR chemoreceptor Srx;
                     pfam10328"
                     /db_xref="CDD:255910"
                     /region_name="7TM_GPCR_Srx"
     Region          81..366
                     /note="7 transmembrane receptor (rhodopsin family);
                     pfam00001"
                     /db_xref="CDD:249497"
                     /region_name="7tm_1"
     Site            94..120
                     /note="propagated from UniProtKB/Swiss-Prot (P18090.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            133..154
                     /note="propagated from UniProtKB/Swiss-Prot (P18090.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            173..196
                     /note="propagated from UniProtKB/Swiss-Prot (P18090.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          218..232
                     /note="propagated from UniProtKB/Swiss-Prot (P18090.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist and antagonist binding (By
                     similarity)"
     Site            223..248
                     /note="propagated from UniProtKB/Swiss-Prot (P18090.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            309..338
                     /note="propagated from UniProtKB/Swiss-Prot (P18090.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          326..333
                     /note="propagated from UniProtKB/Swiss-Prot (P18090.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist and antagonist binding (By
                     similarity)"
     Site            344..366
                     /note="propagated from UniProtKB/Swiss-Prot (P18090.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          352..356
                     /note="propagated from UniProtKB/Swiss-Prot (P18090.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist and antagonist binding (By
                     similarity)"
     Region          463..466
                     /note="propagated from UniProtKB/Swiss-Prot (P18090.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="PDZ-Binding (By similarity)"
     CDS             1..466
                     /coded_by="NM_012701.1:1..1401"
                     /gene="Adrb1"
                     /gene_synonym="B1AR; RATB1AR"
                     /db_xref="GeneID:24925"
                     /db_xref="RGD:2059"
ORIGIN
        1 mgagalalga sepcnlssaa plpdgaataa rllvlasppa sllppasegs aplsqqwtag
       61 mglllalivl livvgnvlvi vaiaktprlq tltnlfimsl asadlvmgll vvpfgativv
      121 wgrweygsff celwtsvdvl cvtasietlc vialdrylai tlpfryqsll trararalvc
      181 tvwaisalvs flpilmhwwr aesdearrcy ndpkccdfvt nrayaiassv vsfyvplcim
      241 afvylrvfre aqkqvkkids cerrfltgpp rppspapsps pgpprpadsl angrsskrrp
      301 srlvalreqk alktlgiimg vftlcwlpff lanvvkafhr dlvpdrlfvf fnwlgyansa
      361 fnpiiycrsp dfrkafqrll ccarraacrr raahgdrpra sgclaragpp pspgapsddd
      421 dddagatppa rllepwagcn ggtttvdsds sldepgrqgf sseskv
//
